![]() ![]() In each Notice of Electronic Filing, the judge assignment is indicated, and a link to the # Judges Copy Requirements and # Judge Specific Requirements is provided. ![]() (Filing fee $402 Receipt number 0539-13030265) Plaintiff will submit summons(es) for issuance. (Kennedy, Mark)ĬOMPLAINT against Xavier Becerra filed by Precise Diagnostics LLC. (Clerk QC note: No affiliate entered in ECF). (Kennedy, Mark) Enhanced text on (dsr).ĬERTIFICATE OF INTERESTED PERSONS/DISCLOSURE STATEMENT by Precise Diagnostics LLC. (Filer confirms contact info in ECF is current.) (Scott, Calvin)ĪDDITIONAL ATTACHMENTS to #1 Complaint (Civil Cover Sheet), by Plaintiff Precise Diagnostics LLC. NOTICE of Attorney Appearance by Calvin Trey Scott on behalf of Precise Diagnostics LLC. (Attachments: #1 Additional Page(s), #2 Additional Page(s)) (Scott, Calvin) Request for Clerk to issue Summons filed by Precise Diagnostics LLC. Clerk to provide copy to plaintiff if not received electronically. Order 6, Plaintiff is provided the Notice of Right to Consent to Proceed Before A U.S. New Case Notes: A filing fee has been paid. Summons issued as to Xavier Becerra, U.S. (Attachments: #1 Additional Page(s), #2 Additional Page(s)) (Scott, Calvin) Modified on (mmw). SUMMONS Returned Executed as to Xavier Becerra served on USAG served on 8/16/22 AUSA served on 8/17/22. Substantial one-stop expertise with precision injection molding, high-performance medical interconnects, complex custom cable assemblies, fiber optics and more helps tomorrow’s in vitro innovations take shape today-for optimized patient care that actively improves lives around the world.This docket was last retrieved on August 23, 2022. Phillips-Medisize, a Molex company, empowers customers with 60+ years of proven product realization proficiency in the medical technology sector and across highly regulated industries. This is why today’s leading organizations often turn to specialized, globally integrated providers who can offer knowledgeable support and state-of-the-art production efficiencies. Supply chain uncertainties, costing concerns, reimbursement models, documentation hurdles and risk mitigation challenges can often further complicate or even entirely disrupt business continuity-measurably impacting product realization initiatives and impeding time to market. ![]() Keeping up with an ever-evolving profusion of safety, quality and regulatory guidelines in this space can be challenging for today’s manufacturers. All related instruments and software algorithms must work together seamlessly to make this possible-so precision design and manufacturing of complex in vitro diagnostic equipment is absolutely imperative. In vitro diagnostics use a complex array of assays and reagents to identify medical conditions by analyzing a patient’s bodily fluids and/or tissue samples. Miniaturization and advancing medical technologies are presenting new opportunities to help tackle these issues.Ĭonsistent with ongoing, human-centered industry shifts toward remote patient monitoring and wearable medical devices, certain point-of-care diagnostic testing can now take place in either clinical settings or an individual’s home. These interdependent dynamics have prompted the need to explore more efficient, personalized and precise diagnostic approaches. The world's geriatric population continues growing dramatically, prompting a related increase in the prevalence of chronic ailments and infectious disease communicability. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |